A. Gontarewicz

G. Sauter, T. Clauditz, W. Wilczak, 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

Abundant expression of mTOR kinase in salivary gland tumors - potentials as therapy target?

G. Sauter, C. Bokemeyer, T. Clauditz, 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cells

I. Nazarenko, R. Schäfer, C. Sers, 2002, Oncogene.

Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.

J. Hauber, A. Nordheim, C. Bokemeyer, 2007, Blood.

Spindle-Cell Variants of Primary Cutaneous Follicle Center B-Cell Lymphomas Are Germinal Center B-Cell Lymphomas by Gene Expression Profiling Using a Formalin-Fixed Paraffin-Embedded Specimen.

R. Spang, W. Klapper, J. Richter, 2017, The Journal of investigative dermatology.

Whole-slide image analysis of the tumor microenvironment identifies low B-cell content as a predictor of adverse outcome in patients with advanced-stage classical Hodgkin lymphoma treated with BEACOPP

A. Rosenwald, W. Klapper, H. Stein, 2020, Haematologica.

Isolation of hematopoietic stem cells from heparinized cadaveric multiple organ donors: potential clinical implications.

M. Ratajczak, M. Ostrowski, M. Żukowski, 1999, Transplantation proceedings.

Inhibition of IL‐6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer

S. Rose-John, H. Kalthoff, G. H. Waetzig, 2015, International journal of cancer.

[Isolation of human mononuclear cells from bone marrow, peripheral blood and cord blood using Ficoll-Paque (Pharmacia) and Gradisol L (Polfa). Comparative study].

M. Ratajczak, M. Honczarenko, B. Machalinski, 1998, Polskie Archiwum Medycyny Wewnetrznej.

Resistance to Danusertib (formerly PHA-739358) in BCR-ABL-Positive Cells Is Mediated by Upregulation of the Drug Transporter Abcg2 and Can Be Suppressed in Vitro by Combination Treatment with Imatinib.

C. Bokemeyer, T. Brümmendorf, S. Balabanov, 2009 .